Study S002690

Antidiabetic Medications and Risk of Cancer

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07628556
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 74799
Start: 2025-03-15
Primary completion: 2025-12-30
Lead sponsor: University of Pecs
Conditions: Cancer
Interventions: DRUG:Metformin; DRUG:sulphonylurea; DRUG:DPP-4 inhibitor; DRUG:GLP-1 Receptor Agonists; DRUG:SGLT-2 inhibitor; DRUG:insulin; DRUG:MET + SU; DRUG:MET + DPP-4 inhibitor; DRUG:MET + GLP-1RA; DRUG:MET + SGLT2i; DRUG:MET + INS
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Overall cancer risk [2016-2022]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.